Literature DB >> 5309537

Chemosterilization of Culex pipiens fatigans Wiedemann by exposure of aquatic stages. 2. Sterilization potential of certain phosphoramides and s-triazines.

K K Grover, M K Pillai.   

Abstract

Many aziridinyl compounds are known to induce high sterility in Culex pipiens fatigans Wiedemann, but as the practical application of these chemosterilants is quite hazardous, compounds such as phosphoramides and s-triazines have been tried against this species. These compounds are relatively less reactive, thermally more stable and less toxic to mammals. The phosphoramides included hempa, N,N,N',N'-tetramethyl-P-piperidino-phosphonic diamide (ENT-51007) and a compound, ENT-60210, whose structure is not known to the authors. The s-triazines employed were hemel, 2,4-diamino-6-morpholino-s-triazine hydrochloride (ENT-51143), 2-amino-4,6-bis (dimethylamino)-s-triazine hydrochloride (ENT-51146), and a compound ENT-60433, whose structure is not known to the authors.The triazines were more toxic than the phosphoramides in both larval and pupal treatments. Among the phosphoramides, hempa and ENT-51007 were quite promising for larval treatment and resulted in 80% and 83% control of reproduction respectively at non-toxic doses. Hempa at a toxic dose induced complete sterility. ENT-60210 was least toxic and least effective. Among the triazines, hexa-substituted hemel was better than tetra-substituted ENT-51146 and cyclic-substituted ENT-51143 in inducing sterility. ENT-51143 was most toxic and least effective. For larval treatment, hempa was better than hemel in inducing sterility while for pupal treatment the latter was better than hempa. Both the compounds produced more sterility in treated females than in treated males. Oviposition was significantly lowered in treated females.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5309537      PMCID: PMC2427595     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  INSECT CHEMOSTERILANTS WITH LOW TOXICITY FOR MAMMALS.

Authors:  S C CHANG; P H TERRY; A B BORKOVEC
Journal:  Science       Date:  1964-04-03       Impact factor: 47.728

2.  Mutagenic effects of alkylating agents.

Authors:  C AUERBACH
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

3.  Metabolism of C14-labeled hemel in male house flies.

Authors:  S C Chang; A B DeMilo; C W Woods; B Borkovec
Journal:  J Econ Entomol       Date:  1968-10       Impact factor: 2.381

Review 4.  Insect chemosterilants.

Authors:  A B Borkovec
Journal:  Adv Pest Control Res       Date:  1966

5.  Effectiveness of hempa as a house fly chemosterilant.

Authors:  G C LaBrecque; P B Morgan; D W Meifert; R L Fye
Journal:  J Med Entomol       Date:  1966-04       Impact factor: 2.278

6.  Asthma: immunological and non-immunological.

Authors:  I Caplin; J T Haynes
Journal:  J Indiana State Med Assoc       Date:  1966-09

7.  Insect chemosterilants. IV. Phosphoramides.

Authors:  P H Terry; A B Borkovec
Journal:  J Med Chem       Date:  1967-01       Impact factor: 7.446

8.  Comparative mutagenicity of two chemosterilants, tepa and hempa, in sperm of Bracon hebetor.

Authors:  J Palmquist; L E LaChance
Journal:  Science       Date:  1966-11-18       Impact factor: 47.728

9.  Sterilization of Culex pipiens fatigans Wiedemann by apholate.

Authors:  M Das
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

  9 in total
  2 in total

1.  The mating ability of males of Culex pipiens fatigans Wiedemann sterilized with apholate or tepa.

Authors:  K K Grover; M K Pillai
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

2.  Chemosterilization of Culex pipiens fatigans Wiedemann by exposure of aquatic stages. 3. Induction of dominant lethal mutations in the F 1 generation by certain aziridines, phosphoramides, and s-triazines.

Authors:  K K Grover; M K Pillai
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.